title: Learning from toxicity patterns in phase I trials during the era of mechanism targeted agents.
authors.affiliation: Drug Development Unit, Christie NHS Trust, Manchester, UK. Electronic address: Alastair.Greystoke@christie.nhs.uk.
authors.forename: A
authors.initials: A
authors.lastname: Greystoke
authors.affiliation: Drug Development Unit, Christie NHS Trust, Manchester, UK.
authors.forename: M
authors.initials: M
authors.lastname: Ranson
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D058990:Molecular Targeted Therapy / Q000009:adverse effects*; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents